Detalhe da pesquisa
1.
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials.
Lancet;
393(10167): 143-155, 2019 01 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30420123
2.
Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.
NEJM Evid;
2(3)2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37213438
3.
Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials.
J Acquir Immune Defic Syndr;
83(3): 310-318, 2020 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31834000
4.
Metabolic profiles of individuals switched to second-line antiretroviral therapy after failing standard first-line therapy for treatment of HIV-1 infection in a randomized, controlled trial.
Antivir Ther;
23(1): 21-32, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28447585
5.
Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial.
Lancet Respir Med;
4(12): 980-989, 2016 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27773665
6.
Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study.
Lancet HIV;
2(11): e492-500, 2015 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26520929
7.
Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.
J Int AIDS Soc;
18: 20016, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26165322
8.
Changes in lipid levels after 48 weeks of dual versus triple therapy observed in the GARDEL study.
J Int AIDS Soc;
17(4 Suppl 3): 19554, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25394061
9.
Duration of anti-tuberculosis therapy and timing of antiretroviral therapy initiation: association with mortality in HIV-related tuberculosis.
PLoS One;
8(9): e74057, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24066096
10.
Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America.
PLoS One;
5(6): e10490, 2010 Jun 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20531956
11.
Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean.
J Acquir Immune Defic Syndr;
51(5): 615-23, 2009 Aug 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19430306
12.
Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean
Artigo
em Inglês
| Arca: Repositório institucional da Fiocruz
| ID: arc-29559
13.
Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study
Artigo
em Inglês
| Arca: Repositório institucional da Fiocruz
| ID: arc-29558
14.
Impact of suppression of viral replication by highly active antiretroviral therapy on immune function and phenotype in chronic HIV-1 infection.
J Acquir Immune Defic Syndr;
30(1): 33-40, 2002 May 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12048361